Mentice AB (STO: MNTC) announces that the company will present its Year-End Q4-2024 interim report for the period October – December via a webcast conference call on February 13, 2025, at 11:00 CET.

‍

During the webcast, CEO Frans Venker and CFO Ulrika Drotz will provide insights into the company's financial performance and strategic developments. The presentation will be followed by a Q&A session, moderated by Carnegie analyst Rikard Engberg.

‍

The presentation will be held in English, and participants are encouraged to register in advance.

‍

For more information on how to join the webcast and participate, please visit https://investor.mentice.com/.

‍

For more information, please contact:
Stacy Hammar, Senior Marketing Manager, Mentice
E-post: stacy.hammar@mentice.com
Mobile: +46 732 345 285

‍

About Mentice
Mentice (STO: MNTC) is the world leader in proficiency based simulation solutions for image guided interventional therapies. Our solutions help healthcare professionals acquire, retain, and enhance their procedural skills driving improved productivity and outcomes. Mentice solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular, and peripheral interventions are just some of the clinical areas covered by our solutions. Learn more about the features and benefits of Mentice solutions at: www.mentice.com

Marketplace| Nasdaq First North Growth Market, Stockholm | Ticker symbol MNTC
Certified Adviser| FNCA Sweden AB